Bell Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.2K | Hold |
115
| – | – | 0.01% | 243 |
|
|
2025
Q1 | $55.8K | Sell |
115
-2
| -2% | -$970 | 0.01% | 211 |
|
|
2024
Q4 | $47.1K | Sell |
117
-3
| -3% | -$1.21K | 0.01% | 227 |
|
|
2024
Q3 | $55.8K | Hold |
120
| – | – | 0.01% | 215 |
|
|
2024
Q2 | $56.2K | Buy |
120
+1
| +0.8% | +$469 | 0.01% | 201 |
|
|
2024
Q1 | $49.7K | Buy |
119
+9
| +8% | +$3.76K | 0.01% | 207 |
|
|
2023
Q4 | $44.8K | Buy |
110
+3
| +3% | +$1.22K | 0.01% | 210 |
|
|
2023
Q3 | $37.2K | Buy |
107
+4
| +4% | +$1.39K | 0.01% | 209 |
|
|
2023
Q2 | $36.2K | Buy |
103
+10
| +11% | +$3.52K | 0.01% | 206 |
|
|
2023
Q1 | $29.3K | Sell |
93
-10
| -10% | -$3.15K | 0.01% | 235 |
|
|
2022
Q4 | $29.7K | Buy |
103
+11
| +12% | +$3.18K | 0.01% | 235 |
|
|
2022
Q3 | $27K | Sell |
92
-4
| -4% | -$1.17K | 0.01% | 217 |
|
|
2022
Q2 | $27K | Buy |
+96
| New | +$27K | 0.01% | 219 |
|
|
2021
Q4 | $18K | Buy |
80
+70
| +700% | +$15.8K | ﹤0.01% | 344 |
|
|
2021
Q3 | $2K | Buy |
+10
| New | +$2K | ﹤0.01% | 1180 |
|